Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunity

European Journal of Medicinal Chemistry 2026

View at publisher
Authors: Zhijie Wang, Zhijie Wang, Haiqi He, Jianwei Xu, Xiaotong Liao, Jun Tan, Chenglong Xu, Jiamin Tan, Lirong Zhang, Qin Wang, Qin Wang, Xixiang Yang
+4 more Yichang Ren, Guangfa Wang, Yanle Zhi, Jianjun Chen
DOI: 10.1016/j.ejmech.2026.118605
Cited by: 1
References: 31

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Cytokine Signaling Pathways and Interactions interferon and immune responses

Publication details

Journal / source
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Volume
306
Pages
118605–118605
Publication date
22 January 2026
Language
EN